Skip to main content
. 2023 Mar 20;8(12):11138–11150. doi: 10.1021/acsomega.2c07959

Figure 3.

Figure 3

Network enrichment analysis. (a) GO functional enrichment analysis of targets for SMP treatment of RA; (b) KEGG pathway enrichment analysis of targets in SMP treatment of RA.